Healthcare Services

Global Crohn’s Disease (CD) Treatment Industry Trends and Market Growth Forecast for 2026–2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Crohn’s Disease (CD) Treatment Market Across 2026–2030?

Recent years have seen a steady expansion in the crohn’s disease (cd) treatment market size. The market is projected to expand from $12.32 billion in 2025 to reach $12.88 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.5%. This growth observed during the historic period is attributable to an increasing inflammatory bowel disease prevalence, limitations of conventional corticosteroids, hospital-centered disease management, delayed diagnosis rates, and reliance on immunomodulators.

The market for Crohn’s disease (CD) treatment is projected to experience robust expansion over the upcoming years, with an anticipated valuation of $16.01 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.6%. During the projected timeframe, this expansion is primarily driven by progress in biologics development, the rise of precision medicine, heightened patient awareness, enhanced diagnostic methodologies, and an uptick in specialized gastroenterology care. Key trends expected within this period encompass the escalating adoption of biologic therapies, the proliferation of targeted small molecule medications, a greater emphasis on achieving long-term disease remission, the development of personalized treatment strategies, and the incorporation of combination therapy protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Crohn’s Disease (CD) Treatment Market?

The future expansion of the Crohn’s disease (CD) treatment market is anticipated to be driven by the rising occurrence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) refers to a collection of persistent inflammatory conditions mainly impacting the gastrointestinal (GI) tract. Treatments for Crohn’s disease (CD) alleviate discomfort, reduce swelling, encourage periods of remission, and improve the general well-being of those affected by chronic inflammatory bowel disease. For example, the United States National Library of Medicine reported in September 2023 that in Canada, the incidence of inflammatory bowel diseases (IBD) was estimated at 30 per 100,000 person years in 2023, with an expected consistent annual increase of approximately 0.58%. By 2023, the prevalence of IBD in Canada reached approximately 825 per 100,000, with predictions that this figure could escalate to 1.1% of the population by 2035. Consequently, the growing prevalence of inflammatory bowel diseases propels the Crohn’s disease (CD) treatment market.

What Segmentation Levels Are Considered In The Crohn’s Disease (CD) Treatment Market?

The crohn’s disease (cd) treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Route Of Administration: Oral, Injectable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Rifaximin

2) By Amino Salicylates: Mesalamine, Sulfasalazine

3) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

4) By Immunomodulators: Azathioprine, Mercaptopurine, Methotrexate

5) By Other Drug Types: Biologic Therapies, Janus Kinase Inhibitors, Small Molecules

What Trends Are Projected To Affect The Crohn’s Disease (CD) Treatment Market?

Leading companies in the Crohn’s disease (CD) treatment market are prioritizing the creation of advanced technologies, particularly non-invasive biomarker-based diagnostic platforms, to elevate disease detection, sharpen monitoring accuracy, and aid in personalized treatment decisions. Non-invasive diagnostic technologies within Crohn’s disease are defined as instruments that examine biological samples without requiring invasive procedures, thereby facilitating earlier detection of inflammation, more effective tracking of disease activity, and an enhanced patient experience. For example, in March 2023, The IRR Chemistry Hub, an interdisciplinary research center located in Scotland, introduced IBDSENSE, a fluorescence-based technology developed to improve the diagnosis and monitoring of inflammatory bowel disease, including Crohn’s disease. This platform gauges the enzyme activity of Granzyme B (GzmB) in patient biosamples, presenting a patient-friendly, non-invasive technique to evaluate disease progression and inform therapeutic selections.

Which Leading Firms Are Contributing To The Growth Of The Crohn’s Disease (CD) Treatment Market?

Major companies operating in the crohn’s disease (cd) treatment market are AbbVie Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Amgen Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Ferring B.V., Eli Lilly and Company, Sanofi S.A., Bristol-Myers Squibb Company, Galapagos NV, Abivax, Biogen Inc., Gilead Sciences, RedHill Biopharma, Prometheus Biosciences, Hoffmann-La Roche

Read the full crohn’s disease (cd) treatment market report here:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Which Regions Are Projected To Dominate The Crohn’s Disease (CD) Treatment Market In The Coming Years?

North America was the largest region in the Crohn’s disease (CD) treatment market in 2025. The regions covered in the crohn’s disease (cd) treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Crohn’s Disease (CD) Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12902&type=smp

Browse Through More Reports Similar to the Global Crohn’s Disease (CD) Treatment Market 2026, By The Business Research Company

Acute Ischemic Stroke Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-diagnosis-global-market-report

Acute Ischemic Stroke Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-drugs-global-market-report

Myocardial Ischemia Global Market Report

https://www.thebusinessresearchcompany.com/report/myocardial-ischemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795